Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Chirag Patel (NPI 1124224936)

Field	Value
Entity Type	Individual
Organization	Chirag Patel
Address	262 Neil Ave
City	Columbus
State	OH
ZIP	43215
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 27, 2007

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

Practice is strongly procedure-driven with a retina/ocular-injection focus: the top revenue lines are intravitreal biologic administrations and related retinal imaging. J0178 (aflibercept) alone generated $1.3M in revenue (61.2% of Medicare revenue), and J2777 (faricimab) and J3590 (unclassified biologics) together add another $276.7K and $169.6K respectively, while retinal imaging (92134) also appears in the top codes at $54.8K. This mix points to an office-based retina practice centered on anti-VEGF and other injectable biologic therapy supported by diagnostic imaging.

Revenue is highly concentrated in a small set of drug-injection codes: the precomputed top-3 codes account for 82.2% of this provider's total Medicare revenue. That concentration means Medicare revenue is largely dependent on continued use and reimbursement of these biologic injection codes (J0178, J2777, J3590), exposing the practice to clinical and reimbursement shifts affecting those specific agents.

The provider is effectively single-payer in this dataset: lifetime Medicare revenue is $2.1M while there is no Medicaid billing on file. This absence of Medicaid activity indicates payer mix is heavily Medicare-weighted, which simplifies payer contracting exposure but raises concentration risk if Medicare policy or utilization changes for retinal injections.

Competitive standing is mixed across the top codes: J0178 produced $1.3M and ranks #595 of 3204 providers nationally (81th percentile; typical, unremarkable volume for this code), indicating solid but not dominant use of aflibercept relative to peers. By contrast J3590 produced $169.6K and ranks #65 of 631 providers nationally (90th percentile; typical, unremarkable volume), showing comparatively stronger national placement for unclassified biologics billing, while J2777 ranks #1040 of 2039 (49th percentile; typical, unremarkable volume), around the median for faricimab.

Utilization patterns show notable E/M and diagnostic intensity: the established-patient E/M code 99213 appears as an extreme outlier (1.1K claims, $67.4K, ranks #4615 of 457151 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code)), and retinal imaging 92134 is also high (2K claims, $54.8K, ranks #1010 of 26868 providers nationally (96th percentile; notably above typical national volume for this code)). These elevated volumes suggest a high visit cadence and heavy use of imaging to support frequent injection visits.

Surgical retina activity is present but limited relative to injection volume: 67028 accounts for $118.8K (5.6% of Medicare revenue) with rank #1000 of 4255 providers (76th percentile; typical, unremarkable volume for this code), while pars plana vitrectomy codes such as 67041 (12 claims, $10.4K, ranks #379 of 461 providers nationally (8th percentile; typical, unremarkable volume for this code)) and 67036 (11 claims, $7.5K, ranks #775 of 832 providers nationally (0th percentile; typical, unremarkable volume for this code)) indicate only modest surgical throughput compared with injection-based care. This pattern reinforces a primarily outpatient injection/imaging service line rather than a high-volume surgical retina center.

Reliance on unclassified drug codes is material and may reflect billing for newer or non-routine agents: J3590 contributed $169.6K (8.0% of Medicare revenue) and ranks #65 of 631 providers nationally (90th percentile; typical, unremarkable volume), while J3490 added $91.7K (4.3% of Medicare revenue) and ranks #1326 of 2838 providers nationally (53th percentile; typical, unremarkable volume). The combined share of these unclassified codes is meaningful and warrants attention when modeling drug cost exposure and procurement practices.

Provider tenure is long-established: the NPI was enumerated on 2007-06-27 (~19 years ago), which aligns with the accumulated lifetime Medicare revenue of $2.1M and suggests the practice has operated in the market for nearly two decades, likely building the steady injection-centric referral base reflected in the claims pattern.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,870	$690	$1.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	9,540	$30	$276.7K
J3590	Unclassified biologics	510	$330	$169.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,310	$90	$118.8K
J3490	Unclassified drugs	60	$1,460	$91.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,140	$60	$67.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,030	$30	$54.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	120	$110	$13.8K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	10	$860	$10.4K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	10	$690	$7.5K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Chirag Patel — 4 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	22	100	840	$680	$729K
J2777	33	70	9,480	$30	$353.3K
J3490	40	50	100	$560	$73.1K
67028	33	150	470	$90	$64K
J3590	22	100	200	$100	$30K
67041	11	20	20	$1,180	$23.5K
67036	43	50	20	$870	$21K
99214	15,234	20,010	100	$70	$11.7K
99213	76	20,000	70	$50	$6.6K
92134	31	1,010	50	$30	$6.3K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Chirag Patel, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Matthew Byun	OH	Retina Specialist (Ophthalmology) Physician	$2.4M	$0
Christiane Hunt	OH	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Lisa Borkowski	OH	Ophthalmology Physician	$1.3M	$0
Mashal Akhter	OH	Retina Specialist (Ophthalmology) Physician	$695.2K	$0

Nearby Providers

Other providers in the same ZIP code as Chirag Patel, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ohiohealth Corporation	OH	General Acute Care Hospital	$0	$215.2M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Southeast, Inc	OH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$40.8M
Mid-ohio Emergency Services, LLC	OH	Emergency Medicine Physician	$0	$38.5M
Nationwide Children's Hospital	OH	Home Infusion Agency	$0	$22.4M
Ohio Emergency Professionals Inc	OH	Emergency Medicine Physician	$0	$21.5M
Premier Care Of Ohio, LLC	OH	Methadone Clinic	$0	$18.2M
Nationwide Children's Hospital Homecare	OH	Home Health Agency	$0	$17.5M
Forward Health LLC	OH	Substance Use Disorder Rehabilitation Clinic/Center	$0	$12.1M
Nationwide Children's Hospital	OH	Dental Clinic/Center	$0	$11.1M

Chirag Patel — Billing Profile & Reimbursement Data

Sign up for Chirag Patel — Billing Profile & Reimbursement Data policy alerts

Chirag Patel — Billing Profile & Reimbursement Data

Sign up for Chirag Patel — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References